NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
17.46
-0.01 (-0.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NAMS Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for NAMS stock have an average target of 43.17, with a low estimate of 37 and a high estimate of 52. The average target predicts an increase of 147.25% from the current stock price of 17.46.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +140.55% | Apr 8, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +197.82% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Maintains $46 → $42 | Strong Buy | Maintains | $46 → $42 | +140.55% | Feb 27, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +129.10% | Jan 28, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +129.10% | Jan 24, 2025 |
Financial Forecast
Revenue This Year
18.38M
from 45.56M
Decreased by -59.66%
Revenue Next Year
17.03M
from 18.38M
Decreased by -7.33%
EPS This Year
-1.87
from -2.56
EPS Next Year
-1.92
from -1.87
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.2M | 61.2M | 264.0M | ||
| Avg | 18.4M | 17.0M | 127.3M | ||
| Low | n/a | n/a | 34.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -40.3% | 232.7% | 1,450.1% | ||
| Avg | -59.7% | -7.3% | 647.2% | ||
| Low | - | - | 101.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.62 | -1.31 | -0.43 | ||
| Avg | -1.87 | -1.92 | -1.49 | ||
| Low | -2.07 | -2.31 | -2.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.